<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">490</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2026.7.2.242-246</article-id>
<title-group><article-title>Comparative Evaluation of Topical 10% Potassium Hydroxide and Intralesional MMR Vaccine in Pediatric Molluscum Contagiosum: A Prospective Interventional Study</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Sharma</surname><given-names>Shantanu</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Saxena</surname><given-names>Deepti</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Noor</surname><given-names>Jaishree</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Danish</surname><given-names>Mohd</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Bharti</surname><given-names>Anshuma</given-names></name></contrib>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><day>30</day><month>05</month><year>2026</year></pub-date>
<volume>7</volume>
<issue>2</issue>
<fpage>242</fpage>
<lpage>246</lpage>
<history>
<date date-type="received"><day>28</day><month>03</month><year>2026</year></date>
<date date-type="accepted"><day>29</day><month>04</month><year>2026</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/490/comparative-evaluation-of-topical-10-potassium-hydroxide-and-intralesional-mmr-vaccine-in-pediatric"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/490/download"/>
<abstract><p>Background: The infection called Molluscum contagiosum (MC) is caused by a virus called a poxvirus and is characterized by small dome-shaped bumps on a child’s skin. MC is often treated with various treatments (some have been around for a long time) however, the best possible options will be safe, effective, easy to apply and tolerated well by children. This study was performed to compare the efficacy and safety of the use of topical 10% Potassium Hydrate (KOH) to the use of intralesional measles, mumps and rubella (MMR) vaccination when using those two treatments for caregivers who have a child with Molluscum contagiosum.
Methods: This prospective study was conducted on 60 children (1-12 years old) with clinically diagnosed molluscum contagiosum and randomly assigned them to two groups of 30. Group A had topical 10% KOH applied, while Group B was treated using intralesional MMR vaccine. Following up for two years, including six months after treatment, the researchers assessed and compared the two groups on treatment response, lesion clearance rate, recurrence rate, and adverse effects associated with the respective treatments.
Results: A complete clearance of the lesions occurred in 86.7% of the patients who received the MMR treatment; however, only 70% had total lesion clearance in the KOH group (p</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Molluscum contagiosum</kwd><kwd>MMR vaccine</kwd><kwd>Potassium hydroxide</kwd><kwd>Pediatric dermatology</kwd><kwd>Immunotherapy</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Hanson D, Diven DG. Molluscum contagiosum. Dermatol Online J. 2003;9(2):2.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Olsen JR, Gallacher J, Piguet V, Francis NA. Epidemiology of molluscum contagiosum in children: a systematic review. Fam Pract. 2014;31(2):130–136.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Berger EM, Orlow SJ, Patel RR, Schaffer JV. Experience with molluscum contagiosum and associated inflammatory reactions in a pediatric dermatology practice: the bump that rashes. Arch Dermatol. 2012;148(11):1257–1264.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Brown J, Janniger CK, Schwartz RA, Silverberg NB. Childhood molluscum contagiosum. Int J Dermatol. 2006;45(2):93–99.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>van der Wouden JC, van der Sande R, Kruithof EJ, Sollie A, van Suijlekom-Smit L, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2017;5:CD004767.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Silverberg NB. Pediatric molluscum contagiosum: optimal treatment strategies. Paediatr Drugs. 2003;5(8):505–512.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Romiti R, Ribeiro AP, Grinblat BM, Rivitti EA, Romiti N. Treatment of molluscum contagiosum with potassium hydroxide: a clinical approach in 35 children. Pediatr Dermatol. 1999;16(3):228–230.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Nofal A, Nofal E. Intralesional immunotherapy of molluscum contagiosum: a new perspective. J Am Acad Dermatol. 2009;60(5):901–902.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Rajouria EA, Amatya A, Karn D. Comparative study of 5% potassium hydroxide solution versus 0.05% tretinoin International Journal of Medical and All Body Health Research www.allmedicaljournal.com cream for molluscum contagiosum in children. Kathmandu Univ Med J. 2011;9(36):291–294.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Handjani F, Behazin E, Sadati MS. Comparison of 10% potassium hydroxide solution versus cryotherapy in the treatment of molluscum contagiosum: an open randomized clinical trial. J Dermatolog Treat. 2014;25(3):249–250.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Metkar A, Pande S, Khopkar U. An open, nonrandomized comparative study of imiquimod 5% cream versus 10% KOH solution in the treatment of molluscum contagiosum. Indian J Dermatol Venereol Leprol. 2008;74(6):614–618.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Chauhan PS, Mahajan VK, Mehta KS, Rawat R. The efficacy and tolerability of intralesional measles-mumps-rubella (MMR) vaccine in the treatment of molluscum contagiosum. Indian Dermatol Online J. 2015;6(3):164–169.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Ahmed I, Agarwal S, Ilchyshyn A, Charles-Holmes S, Berth-Jones J. Liquid nitrogen cryotherapy of common warts: cryo-spray vs. cotton wool bud. Br J Dermatol. 2001;144(5):1006–1009.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Mahajan BB, Naik H. Intralesional immunotherapy with killed Mycobacterium w vaccine versus intralesional candida antigen for the treatment of molluscum contagiosum: a comparative study. J Cutan Aesthet Surg. 2016;9(2):99–103.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Theos AU, Cummins R, Silverberg NB, Paller AS. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial. Cutis. 2004;74(2):134–138, 141– 142.</mixed-citation></ref>
</ref-list></back>
</article>